Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

BAROS

SODIUM BICARBONATE; TARTARIC ACID

Standard Dose
460MG/GM;420MG/GM
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview BAROS is listed in Drugs@FDA under application 018509 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient SODIUM BICARBONATE; TARTARIC ACID Form and strength GRANULE, EFFERVESCENT;ORAL - 460MG/GM;420MG/GM Sponsor MALLINCKRODT INC Submission history Latest submission status date: 1994-01-06 00:00:00.

Structured Monograph

Clinical summary

Approval overview BAROS is listed in Drugs@FDA under application 018509 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient SODIUM BICARBONATE; TARTARIC ACID Form and strength GRANULE, EFFERVESCENT;ORAL - 460MG/GM;420MG/GM Sponsor MALLINCKRODT INC Submission history Latest submission status date: 1994-01-06 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
BAROS (SODIUM BICARBONATE; TARTARIC ACID) | Drug Monograph | MedicHelpline